Qing Zhang (@qingzhanglab) 's Twitter Profile
Qing Zhang

@qingzhanglab

Professor at UT Southwestern Medical Center, Study hypoxia, oxygen sensing pathway and VHL pathway in cancers, including breast and kidney cancers.

ID: 43631962

linkhttps://profiles.utsouthwestern.edu/profile/190788/qing-zhang.html calendar_today31-05-2009 03:02:13

2,2K Tweet

2,2K Followers

1,1K Following

Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

How to treat mRCC #kidneycancer after 1st-line treatment ? Loved the talk by Robert Motzer MD 👉Cabozantinib as 2nd line, and belzutifan as 3rd line are options👇highlights novel drugs include CART, Zanza and others👇#KCRS24 KidneyCAN Toni Choueiri, MD Sumanta K. Pal, MD, FASCO

How to treat mRCC #kidneycancer after 1st-line treatment ? Loved the talk by <a href="/motzermd/">Robert Motzer MD</a> 👉Cabozantinib as 2nd line, and belzutifan as 3rd line are options👇highlights novel drugs include CART, Zanza and others👇#KCRS24 <a href="/kidneycan/">KidneyCAN</a> <a href="/DrChoueiri/">Toni Choueiri, MD</a> <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a>
KidneyCAN (@kidneycan) 's Twitter Profile Photo

This morning, scientists and KidneyCAN staff laced up for the Rock the Run 5k fundraiser! 🏃‍♂️🏃‍♀️💪 A fantastic event supporting kidney cancer research and driving us closer to a cure. Together, we’re making strides! #KCRS24 #KidneyCancer #AcceleratingCures

This morning, scientists and KidneyCAN staff laced up for the Rock the Run 5k fundraiser! 🏃‍♂️🏃‍♀️💪 A fantastic event supporting kidney cancer research and driving us closer to a cure. Together, we’re making strides! #KCRS24 #KidneyCancer #AcceleratingCures
Qing Zhang (@qingzhanglab) 's Twitter Profile Photo

Deeply honored to receive the inaugural AACR/KidneyCAN innovation/discovery grant award #KCRS24. Appreciate wonderful supports from ⁦AACR⁩ ⁦KidneyCAN⁩. This won’t be possible without strong supports from ⁦UTSW Simmons Cancer Center⁩ ⁦KidneyCancerProgram⁩ ⁦UTSW Department of Pathology

Deeply honored to receive the inaugural AACR/KidneyCAN innovation/discovery grant award #KCRS24. Appreciate wonderful supports from ⁦<a href="/AACR/">AACR</a>⁩ ⁦<a href="/kidneycan/">KidneyCAN</a>⁩. This won’t be possible without strong supports from ⁦<a href="/utswcancer/">UTSW Simmons Cancer Center</a>⁩ ⁦<a href="/KCPUTSW/">KidneyCancerProgram</a>⁩ ⁦<a href="/UTSW_Pathology/">UTSW Department of Pathology</a>⁩
OncoDaily (@oncodaily) 's Twitter Profile Photo

Honored to receive the inaugural AACR/KidneyCAN innovation/discovery grant award - Qing Zhang (UTSW Simmons Cancer Center) oncodaily.com/104521.html #KCRS24 #AACR #KidneyCAN #InnovationGrant #DiscoveryAward #OncoDaily #Oncology

Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

✨✨SUBMISSION DEADLINE EXTENDED✨✨ Abstract submissions for #IKCSNA24 now accepted through **Sept 3** Submit: 🧡LBAs 🧡Original research (complete or in-progress) 🧡Encore abstracts 🧡Case reports 🧡And more! Guidelines at the submission portal: kidneycancer.swoogo.com/IKCSNA24/cfs/5…

✨✨SUBMISSION DEADLINE EXTENDED✨✨

Abstract submissions for #IKCSNA24 now accepted through **Sept 3**

Submit: 
🧡LBAs 
🧡Original research (complete or in-progress)
🧡Encore abstracts 
🧡Case reports 
🧡And more!

Guidelines at the submission portal: kidneycancer.swoogo.com/IKCSNA24/cfs/5…
Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

We're bringing #IKCSNA24 to Louisville! 📊 Abstract submissions open through Sept 3 (Extended!) 🐣 Early bird registration through Oct 10 See you for the 2024 IKCS: North America in Louisville, KY from Nov 7-9! bit.ly/45CgNiV

AACR (@aacr) 's Twitter Profile Photo

We congratulate Qing Zhang, PhD, one of the 2024 recipients of the AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants. We look forward to his insights on potential therapeutic options that can reverse drug resistance to HIF-2α inhibitors in kidney cancer. KidneyCAN

We congratulate Qing Zhang, PhD, one of the 2024 recipients of the AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants. We look forward to his insights on potential therapeutic options that can reverse drug resistance to HIF-2α inhibitors in kidney cancer. 
<a href="/kidneycan/">KidneyCAN</a>
Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

⌛ FINAL DAY!! Today is the last day to submit your #IKCSNA24 abstract! We want to see your best #kidneycancer research. Submit here: bit.ly/45CgNiV #rcc #renalcellcarcinoma #cancerresearch

UTSW Department of Pathology (@utsw_pathology) 's Twitter Profile Photo

📢 Big announcements UTSW Department of Pathology! Qing Zhang (Qing Zhang) has been promoted to Professor. Dr. Zhang has also been appointed Director of Investigative Pathology! 🎉 Srinivas Malladi (Malladi Lab - UTSW) has been promoted to Associate Professor with tenure! 🍾 Congrats to both!

📢 Big announcements <a href="/UTSW_Pathology/">UTSW Department of Pathology</a>!

Qing Zhang (<a href="/QingZhangLab/">Qing Zhang</a>) has been promoted to Professor. Dr. Zhang has also been appointed Director of Investigative Pathology! 🎉

Srinivas Malladi (<a href="/MalladiLab/">Malladi Lab - UTSW</a>) has been promoted to Associate Professor with tenure! 🍾

Congrats to both!